TY - JOUR
T1 - Regulation of rat kidney mesangial cell phospholipase A2
AU - Hack, Nashrudeen
AU - Tay, Agnes
AU - Schultz, Aylit
AU - Muzin, Nicholas
AU - Clayman, Paula
AU - Egan, Sean
AU - Skorecki, Karl L.
PY - 1996/1
Y1 - 1996/1
N2 - 1. The precursor of eicosanoids is arachidonic acid, which emanates from the cleavage of the sn-2 position of phospholipids by phospholipase A2 (PLA2). Eicosanoids have diverse physiological and pathophysiological effects in the kidney. The regulation of phospholipase A2 has important implications for kidney function. 2. In the current communication we focus our attention on mesangial cell cytosolic PLA2 (cPLA2) and its regulation at the post-translational and post-transcriptional level. 3. At the post-translational level, using site directed mutagenesis of cPLA2 and a dominant negative ras, we have demonstrated that cPLA2 can be phosphorylated by mitogen activated protein (MAP-2) kinase leading to increased cPLA2 enzymatic activity. 4. At the post-transcriptional level we show that the half-life of cPLA2 mRNA in mesangial cells is significantly increased when mesangial cells are stimulated by mitogens. We further demonstrate the presence of three ATTTA motifs in the 3′ untranslated region (′ UTR) of the cPLA2 cDNA. 5. Using chimeric constructs bearing the 3′ UTR from rat cPLA2 fused downstream of the luciferase reporter, we demonstrate that this region exerts a destabilizing effect on cPLA2. 6. We have isolated and mapped genomic DNA and polymorphic markers for cPLA2 in the human and rat.
AB - 1. The precursor of eicosanoids is arachidonic acid, which emanates from the cleavage of the sn-2 position of phospholipids by phospholipase A2 (PLA2). Eicosanoids have diverse physiological and pathophysiological effects in the kidney. The regulation of phospholipase A2 has important implications for kidney function. 2. In the current communication we focus our attention on mesangial cell cytosolic PLA2 (cPLA2) and its regulation at the post-translational and post-transcriptional level. 3. At the post-translational level, using site directed mutagenesis of cPLA2 and a dominant negative ras, we have demonstrated that cPLA2 can be phosphorylated by mitogen activated protein (MAP-2) kinase leading to increased cPLA2 enzymatic activity. 4. At the post-transcriptional level we show that the half-life of cPLA2 mRNA in mesangial cells is significantly increased when mesangial cells are stimulated by mitogens. We further demonstrate the presence of three ATTTA motifs in the 3′ untranslated region (′ UTR) of the cPLA2 cDNA. 5. Using chimeric constructs bearing the 3′ UTR from rat cPLA2 fused downstream of the luciferase reporter, we demonstrate that this region exerts a destabilizing effect on cPLA2. 6. We have isolated and mapped genomic DNA and polymorphic markers for cPLA2 in the human and rat.
KW - Cytosolic phospholipase A
KW - Mesangial cells
KW - Mitogen activated protein kinase
KW - Post-transcriptional regulation
KW - Post-translational regulation
KW - Ras
UR - http://www.scopus.com/inward/record.url?scp=0029689587&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1681.1996.tb03065.x
DO - 10.1111/j.1440-1681.1996.tb03065.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 8713499
AN - SCOPUS:0029689587
SN - 0305-1870
VL - 23
SP - 71
EP - 75
JO - Clinical and Experimental Pharmacology and Physiology
JF - Clinical and Experimental Pharmacology and Physiology
IS - 1
ER -